Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00573404 · ClinicalTrials.gov registry record · Phase 1
Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors
A Phase 1 study, sponsored by Vanderbilt-Ingram Cancer Center.
- Terminated
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00573404: Clinical Trial Phase 1 study, sponsored by Vanderbilt-Ingram Cancer Center.
NCT00573404 is a Phase 1 study that was terminated before completion, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00573404, a Phase 1 study, was terminated before completion, sponsored by Vanderbilt-Ingram Cancer Center.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
RATIONALE: Imatinib mesylate and sunitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is studying the side effects and best dose of imatinib mesylate given together with sunitinib in treating patients with gastrointestinal stromal tumors.
Interventions
- DRUG imatinib mesylate
- OTHER pharmacological study
- DRUG sunitinib malate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2007-07 |
| Est. Completion | 2011-03 |
| Phase | Phase 1 |
Why NCT00573404 stopped before completion
NCT00573404 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 3 interventions - of which imatinib mesylate is the first listed.
NCT00573404 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00573404 about?
NCT00573404 is a clinical study titled "Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors". RATIONALE: Imatinib mesylate and sunitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is studying the side effects and best dose of imatinib mesylate given together with sunitinib in treating patients with gastrointestinal ...
What is the current status of trial NCT00573404?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2007-07. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00573404?
The interventions under investigation include: imatinib mesylate (DRUG), pharmacological study (OTHER), sunitinib malate (DRUG).
Who is sponsoring clinical trial NCT00573404?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00573404's enrollment target sits among peer trials
6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia